Hudson Bay Capital Management LP Recursion Pharmaceuticals, Inc. Transaction History
Hudson Bay Capital Management LP
- $24.1 Billion
- Q4 2024
A detailed history of Hudson Bay Capital Management LP transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 77,500 shares of RXRX stock, worth $594,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,500
Previous 90,000
13.89%
Holding current value
$594,425
Previous $593,000
11.8%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RXRX
# of Institutions
341Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$261 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$248 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$191 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$133 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$112 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.38B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...